K. Diekmann Et Al. , "Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group," JOURNAL OF NEUROLOGY , vol.267, no.7, pp.2130-2141, 2020
Diekmann, K. Et Al. 2020. Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group. JOURNAL OF NEUROLOGY , vol.267, no.7 , 2130-2141.
Diekmann, K., Kuzma-Kozakiewicz, M., Piotrkiewicz, M., Gromicho, M., Grosskreutz, J., Andersen, P. M., ... de Carvalho, M.(2020). Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group. JOURNAL OF NEUROLOGY , vol.267, no.7, 2130-2141.
Diekmann, Kristin Et Al. "Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group," JOURNAL OF NEUROLOGY , vol.267, no.7, 2130-2141, 2020
Diekmann, Kristin Et Al. "Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group." JOURNAL OF NEUROLOGY , vol.267, no.7, pp.2130-2141, 2020
Diekmann, K. Et Al. (2020) . "Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group." JOURNAL OF NEUROLOGY , vol.267, no.7, pp.2130-2141.
@article{article, author={Kristin Diekmann Et Al. }, title={Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group}, journal={JOURNAL OF NEUROLOGY}, year=2020, pages={2130-2141} }